Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) EPS (Weighted Average and Diluted): 2014-2024

Historic EPS (Weighted Average and Diluted) for Rockwell Medical (RMTI) over the last 9 years, with Dec 2024 value amounting to -$0.03.

  • Rockwell Medical's EPS (Weighted Average and Diluted) fell 225.00% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 200.00%. This contributed to the annual value of -$0.03 for FY2024, which is 91.89% up from last year.
  • As of FY2024, Rockwell Medical's EPS (Weighted Average and Diluted) stood at -$0.03, which was up 91.89% from -$0.37 recorded in FY2023.
  • In the past 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in FY2024 and a low of -$3.83 during FY2021.
  • In the last 3 years, Rockwell Medical's EPS (Weighted Average and Diluted) had a median value of -$0.37 in 2023 and averaged -$0.57.
  • As far as peak fluctuations go, Rockwell Medical's EPS (Weighted Average and Diluted) crashed by 834.15% in 2021, and later spiked by 91.89% in 2024.
  • Over the past 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) (Yearly) stood at -$0.41 in 2020, then tumbled by 834.15% to -$3.83 in 2021, then skyrocketed by 65.80% to -$1.31 in 2022, then skyrocketed by 71.76% to -$0.37 in 2023, then spiked by 91.89% to -$0.03 in 2024.